Clinical Trial Update: Selective Complex Fractionated Atrial Electrograms (CFAE) Targeting for Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating selective complex fractionated atrial electrograms (CFAE) targeting for atrial fibrillation has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2014-06-03